Results were broadly in line with expectations with organic EBITDA growth beating, but absolute figure in line. Most important, company maintained its guidance of organic EBITDA growth to be within the 4-8% rangeBased on the Q2 results we expect to only fine tune our estimates, but expect the share price to react positively todayWe reiterate our Buy rating with a TP of EUR 64